Who
Neal C. Bradsher
Director and 10% owner
Company insider
Files Form 4 as: Director and 10% owner, Lineage Cell Therapeutics; Director and 10% owner, STAAR Surgical; 10% owner, Insight Molecular Diagnostics; 10% owner, Comarco; Director and 10% owner, Questcor Pharmaceuticals; 10% owner, Palomar Medical Technologies.
In numbers
- Trades disclosed
- 453
- Buys
- 104
- Sells
- 15
- Bought
- $142.5M
- Sold
- $149.0M
- Companies
- 6
- Companies where not an officer
- 6
- First trade
- 1 Jan 2006
- Last trade
- 1 Jul 2026
- Last filed
- 2 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jul 2026filed 2 Jul 2026 | LCTX Lineage Cell Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | LCTX Lineage Cell Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
| 18 Jun 2026filed 22 Jun 2026 | STAA STAAR Surgicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —11,145 at $0.00 | filing |
| 18 Jun 2026filed 22 Jun 2026 | STAA STAAR Surgicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —11,145 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | STAA STAAR Surgicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —7,524 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | STAA STAAR Surgicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —7,524 at $0.00 | filing |
| 10 Feb 2026filed 12 Feb 2026 | IMDX Insight Molecular DiagnosticsDiagnostics & Labs | SEC FORM 4 Bought | $3.0M521,739 at $5.75 | filing |
| 10 Feb 2026filed 12 Feb 2026 | IMDX Insight Molecular DiagnosticsDiagnostics & Labs | SEC FORM 4 Bought | —0 at $0.00 | filing |
| 9 Jan 2026filed 13 Jan 2026 | STAA STAAR SurgicalMedical Devices | SEC FORM 4 Bought | $606K27,485 at $22.05 | filing |
| 9 Jan 2026filed 13 Jan 2026 | STAA STAAR SurgicalMedical Devices | SEC FORM 4 Bought | —0 at $0.00 | filing |
| 8 Jan 2026filed 8 Jan 2026 | STAA STAAR SurgicalMedical Devices | SEC FORM 4 Bought | $71K3,240 at $21.94 | filing |
| 8 Jan 2026filed 8 Jan 2026 | STAA STAAR SurgicalMedical Devices | SEC FORM 4 Bought | —0 at $0.00 | filing |
| 7 Jan 2026filed 8 Jan 2026 | STAA STAAR SurgicalMedical Devices | SEC FORM 4 Bought | $1.5M66,467 at $22.00 | filing |
| 7 Jan 2026filed 8 Jan 2026 | STAA STAAR SurgicalMedical Devices | SEC FORM 4 Bought | —0 at $0.00 | filing |
| 6 Jan 2026filed 8 Jan 2026 | STAA STAAR SurgicalMedical Devices | SEC FORM 4 Bought | $3.9M186,946 at $21.01 | filing |
| 6 Jan 2026filed 8 Jan 2026 | STAA STAAR SurgicalMedical Devices | SEC FORM 4 Bought | —0 at $0.00 | filing |
| 6 Jan 2026filed 8 Jan 2026 | STAA STAAR SurgicalMedical Devices | SEC FORM 4 Bought | $3.4M150,000 at $22.38 | filing |
| 6 Jan 2026filed 8 Jan 2026 | STAA STAAR SurgicalMedical Devices | SEC FORM 4 Bought | —0 at $0.00 | filing |
| 21 Nov 2025filed 21 Nov 2025 | STAA STAAR SurgicalMedical Devices | SEC FORM 4 Bought | $22.2M797,486 at $27.86 | filing |
| 21 Nov 2025filed 21 Nov 2025 | STAA STAAR SurgicalMedical Devices | SEC FORM 4 Bought | —0 at $0.00 | filing |
News
Alnylam Pharmaceuticals (NASDAQ:ALNY) versus Oncocyte (NASDAQ:IMDX) Head to Head ComparisonIMDX · dailypolitical.com · 21 Oct 2026Oncocyte (NASDAQ:IMDX) and Alnylam Pharmaceuticals (NASDAQ:ALNY) Critical SurveyIMDX · tickerreport.com · 14 Oct 2026Wall Street Zen Upgrades STAAR Surgical (NASDAQ:STAA) to BuySTAA · themarketsdaily.com · 12 Oct 2026
0 headlines in the last 90 days name Neal C. Bradsher; 3 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.